期刊文献+

高血压脑出血术后患者单病例随机对照临床试验 被引量:8

Randomized Controlled Trials in Individual Pantient of Third Stage of Hypertension Intracerebral Hemorrhage
下载PDF
导出
摘要 [目的]通过对高血压脑出血(Hypertensive intracerebral hemorrhage,HICH)术后患者的中医个体化治疗,研究单病例随机对照试验在中医药临床研究中的可行性。[方法]按照HICH的诊断标准纳入病例4例。合格病例采用单病例随机对照设计,每个病例研究分为3轮,每轮为2期,即治疗期和对照期,每期为4周,每1期开始前1周为洗脱期。每一轮治疗以计算机随机数字法简单随机分组,拟定随机化方案,治理怄气采用中医辨证治疗和常规基础治疗,对照期采用常规治疗和安慰剂,疗效指标为主要症状积分、血清IL-6、血肿周围脑水肿或脑梗塞的程度、神经功能缺损程度分级。逐日在固定时间记录主要症状积分。实验室治疗、影像学指标及神经功能缺损程度分级在试验前和每期试验后各记录1次。[结果]4例患者中医症状积分每轮均有不同程度的改善,其中1例部分改善,3例全部改善。4例患者每轮治疗期和对照期相比,IL-6、周围脑水肿或脑梗塞的程度及神经功能缺损程度评分均有一定程度的下降,治疗期均明显好于对照期。其中,4例患者全部三轮治疗期和对照期IL-6的数据合并后,差异有统计学意义(P<0.05)。[结论]单病例随机对照试验的研究方法能体现中医个性化的优势,该设计方案应用于中医药临床研究具有可行性。 [ Objective]To study the feasibility and advantages of randomized controlled trials in individual patient through the TCM individual treatment for hypertension intracerebral hemorrhage. [Methods ] The patients were enrolled according to the diagnosis standard of HICH. The randomized controlled design was adopted in the trial. Each phase of was 4 studied in 3 rounds, each round was divided into 2 phases, namely the treatment phase and control phase, each phase was of 4 weeks, and the first week of each phase was taken as the elution time. In each round, the randomized list was given by the computer for grouping the patients and the randomized plan was made. For the treatment phase, the Chinese medicinal decoctions based on the syndrome differentiation and the routine basic treatment were applied, whilst for the control phase, the routine basic treatment was performed. The indices of effica- cy included the scores of main symptom; IL-6, morphology index and clinical curative effect evaluation. The patient recorded the symptom score at the same time each day. Before and after each phase IL-6, morphology index and clinical curative effect evaluation were tested and recorded as well. [1Le- sults] The TCM symptom scores of these four HICH patients were improved to different degrees in three rounds. Of them, one was partially improved and three completely improved. In the comparison of each treatment and control phase of the 4 patients, IL-6, morphology index and clinical curative effect evaluation were both decreased to different degrees, the treatment phase was better than the control phase. After the date of IL-6 of all 3 rounds of the patients were summed up, it showed the statistical difference. [Conclusion]The studying method of randomized controlled trials in individual patient is able to embody the advantages of TCM individual treatment,and application of this design to the clinical studies of Chinese medicine is useful and feasible.
出处 《浙江中医药大学学报》 CAS 2012年第8期871-873,886,共4页 Journal of Zhejiang Chinese Medical University
基金 浙江省医药卫生科学研究基金课题(2009A154)~~
关键词 HICH 单病例随机对照试验 个性化治疗 hypertension ntracerebral hemorrhage (HICH) randomized controlled trials in individual patient(N-of-1 ) individual treatment
  • 相关文献

参考文献9

二级参考文献44

  • 1赵一鸣.循证医学如何定位?[J].中华医学杂志,2004,84(22):1921-1925. 被引量:14
  • 2刘建平.单个病例随机对照试验的设计与应用[J].中国中西医结合杂志,2005,25(3):252-254. 被引量:23
  • 3赖世隆.中医药临床疗效评价因果关联推断的探讨[J].中国中西医结合杂志,2005,25(4):293-296. 被引量:17
  • 4王家良.临床流行病学[M].2版.上海:上海科学技术出版社.2002:143-144. 被引量:2
  • 5Evidence-Based Medician Working Group. Progress in Evidence- Based Medicine[J]. JAMA, 2008,300 (15) : 1814 - 1816. 被引量:1
  • 6Guyatt GH, Keller JL, Jaeschke R, et al. The n-of-1 randomized controlled trial., clinical usefulness. Our three-year experience [J]. Ann Intern Med, 1990, 112 (4):293 - 299. 被引量:1
  • 7March L,Irwig L,Schwarz J,et al. N-of-1 trials compa- ring a non-steroidal anti-inflammatory drug with parac- etamoi in osteoarthritis [J].BMJ, 1994,309(6961) : 1041-1045. 被引量:1
  • 8Kawakita K, Shichidou T, Inoue E, et al. Do Japanese style acupuncture and moxibustion reduce symptoms of the common cold? [J]. Evid Based Complement Alternat Med, 2008,5(4) :481 - 489. 被引量:1
  • 9Tsapas A, Matthews DR. N of 1 trials in diabetes., mak- ing individual therapeutic decisions [J]. Diabetologia, 2008,51(6) :921 - 925. 被引量:1
  • 10Arnold DF, Burton J, Shine B, et al. An "n-of-l" placebo- controlled crossover trial of intravenous immunoglohulin as adjuvant therapy in refractory pemphigus vulgaris [J]. Br J Dermatol, 2009,160(5) :1098 - 1102. 被引量:1

共引文献92

同被引文献70

  • 1张惠勇,李欣,倪伟,陈凤鸣,邵长荣.支气管扩张证中医辨证分型规律的研究[J].上海中医药杂志,2005,39(1):16-18. 被引量:41
  • 2刘建平.单个病例随机对照试验的设计与应用[J].中国中西医结合杂志,2005,25(3):252-254. 被引量:23
  • 3傅鹰.单病例随机对照治疗试验[J].药物流行病学杂志,1994,3(1):43-44. 被引量:5
  • 4国家中医药管理局.中医病症诊断疗效标准[M].南京:南京大学出版社,1994:186. 被引量:1429
  • 5Guyatt GH, Keller JL, Jaeschke R, et al. The n-of- 1 randomized controlled trial: clinical usefulness [ J ]. Ann Intern Med, 1990, 112 (4) :293-299. 被引量:1
  • 6Guyatt G, Rennie D. User' s guides to the medical literature: a manual for evidence-based clinical practice [ M ]. Chicago: American Medical Association Press ,2002:3-11. 被引量:1
  • 7支气管扩张症的诊断和治疗的专家共识写作组.支气管扩张症的诊断和治疗的专家共识[J].中华结核和呼吸杂志,2013,36(8):563-566. 被引量:2
  • 8Guyatt G, Sackett D, Adachi J, et al. A clinician' s guide for conduction randomized trials in individual patients [ J]. CAMJ, 1988,13 ( 139 ) : 497-503. 被引量:1
  • 9Huang Haiyin, Yang Peilan, Xue Jingjing, et al. Evaluating the Individualized Treatment of Traditional Chinese Medicine : A Pilot Study of N-of-1 Trials[J]. Evid Based Complement Alternat Med,2014. doi: 10.1155/2014/148730. 被引量:1
  • 10Pasteur MC, Bilton D, Hill AT, et al. British Thoracic Society Guideline for non-CF Bronchiectasis [ J ]. Thorax,2010,65 ( 7 ) : 577. 被引量:1

引证文献8

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部